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Chapter 1 
Synthesis of Natural Product Analogue of (-)-Pironetin 
1. Introduction 
 
Figure 1: (a) (–)-pironetin, natural product (b) pironetin analogue, target of synthesis 
 
The natural product (–)-pironetin was originally isolated from the fermentation broth of 
the bacteria Streptomyces prunicolor PA-48153 and Streptomyces sp. NK 10958 by two 
independent groups, the Kobayashi and Yoshida groups, in 1994
 
(1)
 
(2). While initially its 
biological activity was recognized as a plant growth regulator
 
(2), further investigation 
determined that it demonstrated the potential for tumor-inhibiting activity
 
(3)
 
(4). Specifically, it 
has been indicated that pironetin and pironetin derivatives bind α-tubulin (4). The protein α-
tubulin, along with β-tubulin, are subunits which make up microtubules, polymeric cell 
components which play important roles in cell structure, cell growth, and mitotic division
 
(4). 
Unlike other tubulin-targeting molecules which bind β-tubulin, (–)-pironetin has been shown to 
bind to α-tubulin, thus preventing tubulin assembly and inhibiting the mitotic phase of the cell 
cycle
 
(4). This activity demonstrates potential applications against tumor growth. 
 
 
Figure 2: Summary of the (a) Crimmins, (b) Cossy, and (c) Enders Syntheses of (–)-pironetin 
 
Several total synthetic methods have been developed for (–)-pironetin (5) (6) (7) (8). The 
Crimmins synthesis (Figure 2a) is based on iterative aldol additions to build the substituted alkyl 
chain, with lactone formation being the final step
 
(5). The key steps of the Cossy synthesis 
(Figure 2b) are the titanium-mediated crotylation and methylation of an aldehyde, followed by 
ozonolysis and titanium-mediated allylation, and use of Grubbs’ II catalyst ring-closing 
mechanism to generate the lactone ring in the final step
 
(6). The Enders synthesis (Figure 2c) is 
based on their SAMP/RAMP methodology and is a two-part synthesis where the chain and the 
lactone are synthesized in separate pathways and combined to produce the final product
 
(8). 
 
Various efforts have been made to synthesize derivatives of pironetin
 
(9). The first part of 
the work I have completed is the synthesis of an analogue of pironetin (Figure 1a) whose chain is 
truncated so that carbon 10 is dimethyl-substituted and no longer a stereocenter (Figure 1b; 
structure 1, scheme 1, below), using the Crimmins iterative aldol addition methodology. The 
advantage of this iterative aldol approach is that it can be easily adapted to the synthesis of 
simplified pironetin analogues.  
 
By examining the biological activity of this pironetin analogue, greater insight into the 
binding mechanism of pironetin and its derivatives on α-tubulin could be gained. An improved 
understanding of the biologically relevant site of the pironetin molecule could help advance the 
development of a potential cancer treatment. In addition, if the biological activity of this 
truncated pironetin analogue were found to be similar to that of pironetin, this molecule could 
theoretically be more conducive to pharmaceutical development than pironetin, as the reduction 
in number of stereocenters reduces the need for stereoselectivity.  
 
2. Thiazolidinethione Aldol Chemistry and Diastereoselectivity 
This research work followed the scheme for pironetin synthesis as described by Anne-Marie 
Dechert Schmitt, a graduate student in the Crimmins group (5) (7). An advantage of the 
thiazolidinethione aldol addition technology is the access it offers to both the non-Evans syn and 
Evans syn addition products in high yield by varying the amount and identity of base used (7) 
(10). By using 1 equivalent of amine base (such as Hünig’s base), the non-Evans product can be 
obtained, whereas 2 equivalents of base plus NMP will give the Evans syn product (Figure 3). 
One possible explanation of the role of the added base in forcing the Evans syn product is in 
coordinating to the titanium metal center (see transition state a, Figure 3) thus preventing the 
coordination of the thioketone sulfur to the titanium center which had controlled the non-Evans 
addition (see transition state b, Figure 3). 
 
Figure 3: Access to Evans and non-Evans aldol adducts from thiazolidinethione auxiliary esters 
 
However, for acetate aldol additions, high stereoselectivity has historically been more 
difficult to achieve, due to the unsubstituted α carbon (11). To account for this, an approach 
developed by Mariam Shamszad, another student in the Crimmins lab, was adopted, where it was 
found that a highly sterically hindered substituent on the thiazolidinethione auxiliary would 
improve diastereoselectivity (11). While there are multiple reasonable possibilities for the 
mechanism, one proposed transition state resembles the “non-Evans” enolate mechanism (Figure 
3), forming an analogous “chelated chair” structure X seen in figure 4 (11).  
 
 
Figure 4: Possible transition state for selectivity of mesityl-substituted thiazolidinethione auxiliary 
acetate aldol chemistry 
 
As seen in the proposed transition state structure (figure 4), this possibility suggests that 
the steric bulk of the mesityl substituent forces the stereochemistry of the R group. 
 
 
 
 
 
 
3. Retrosynthesis 
 
Scheme 1.1: Retrosynthetic analysis of pironetin isopropyl analogue 
 
Retrosynthetically, pironetin analogue 1 can be ultimately synthesized through a series of 
aldol addition reactions, such as the reaction between 3 and 4, which itself can be prepared from 
5 and 6, itself prepared from 7 and 8. At its most basic level, this synthesis is a series of repeated 
aldol reactions. 
 
 
4. Completed Work 
 
Scheme 1.2: Synthesis of L-valinol derived thiazolidinethione auxiliary 
 
My synthetic work began with the preparation of thiazolidinethione 10 from L-valinol 9 
under standard thiazolidinethione formation conditions. Then, thiazolidinethione 10 was acylated 
with propionyl chloride and base to give acylated thione 7.  
 
 
Scheme 1.3: Acetal aldol addition towards synthesis of pironetin analogue 
 
In preparation for the aldol addition step, aldehyde 11 was converted to its dimethyl acetal 8 
using TsOH and methanol over two distillations. Next, titanium mediated aldol addition of 
acylated thione 7 and acetal 8 was carried out using SnCl4 as a Lewis acid; this gave 
thiazolidinethione 12 and unreacted starting material, thione 7. Initially, due to difficulty of 
removing this starting material and out of concern over the storage stability of aldehyde 6, 
thiazolidinethione 12 was reduced with NaBH4 to alcohol 13. Alcohol 13 was then oxidized with 
oxalyl chloride to give aldehyde 6; however, the product of this reaction could not be 
satisfactorily purified. Instead, a direct approach was attempted wherein thiazolidinethione 12 
was reduced with DIBAL to aldehyde 6. This approach gave a satisfactory yield of aldehyde 6, 
and this product was taken forward. 
 
 
Scheme 1.4: Towards the synthesis of mesityl-substituted auxiliary 5 
 
In order to ensure high diastereoselectivity of aldehyde 4 in the acetate aldol addition, a mesityl-
substituted thiazolidinethione 5 was used. To begin the synthesis of thione 5, first indanol-
derived chiral ligand 16 was formed by imide addition of indanol 14 and benzaldehyde 15. 
Vanadium-mediated monoxidation of disulfide 17 gave thiosulfinate 18. Next, thiosulfinate 18 
was taken to sulfinamide 19 through the formation of lithium amide and displacement of the tert-
butyl thiol. Sulfinamide 19 was then reacted with chloroacetaldehyde to form imine 20. 
 
 
Scheme 1.5: Completion of the synthesis of mesityl-substituted auxiliary 5 
 
The addition of Grignard 21, prepared from bromomesitylene with magnesium, to imine 20, 
followed by standard thiazolidinethione formation conditions, gave thiazolidinethione 22. 
Acetylation of thiazolidinethione 22 yielded mesityl-substituted thiazolidinethione auxiliary 5.  
 
 
Scheme 1.6: Acetal aldol addition towards synthesis of pironetin analogue 
 
Titanium mediated acetate aldol addition of thiazolidinethione 5 and aldehyde 6 was carried out 
to give thiazolidinethione 23. In order to protect the primary alcohol group during the next 
DIBAL reduction step, TES triflate was added to thione 23 in the presence of base 2,6-lutidine, 
yielding TES-protected thione 24. This TES-protected thione 24 was then reduced with DIBAL 
to give aldehyde 4.  
 
Next, titanium mediated aldol addition of thiazolidinethione auxiliary 3 and TES-protected 
aldehyde 4 was carried out, yielding thiazolidinethione 25, which underwent TES-protection as 
above to yield TES-protected thione 26. This thione 26 was then reduced with DIBAL to yield 
TES-protected aldehyde 2. Next, a Horner-Wadsworth-Emmons reaction was carried out with 
aldehyde 2 and a phosphonate ester 27 with sodium hydride and excess sodium to yield 
unsaturated ester 28. Removal of the TES protecting groups was carried out using the weak acid 
PPTS, followed immediately by the formation of the lactone ring from the addition of heat to 
yield the final product, pironetin analogue 1 (132 mg, 47% yield). Also recovered was 147 mg 
(48% yield) of uncyclized ester 29, which was identified as the non-TES-protected version of the 
ester starting material – in other words, unreacted starting material. This mass accounts for the 
majority of the mass that was not converted into 1, meaning that very little mass was actually lost 
in this reaction. 
  
Chapter 2 
Towards a Synthesis of Aquatolide 
1. Introduction 
 
Figure 5: Correct (left) and originally proposed (right) structures of aquatolide 
 
Aquatolide 30 is a sesquiterpene lactone, originally isolated from the aquatic plant 
Astericus aquaticus. Its structure was originally proposed as 31, but Lodewyk et al.
 
(12) were 
able to determine the correct structure. Recently, Hiemstra and his coworkers (13) were able to 
complete a total synthesis of this molecule, using a [2+2] photocycloaddition as the key step for 
the formation of the fused tricyclic core. 
 
Scheme 2.1: Hiemstra synthesis of aquatolide 
 
The goal of my latter work has been to attempt this same synthesis using similar 
chemistry but a novel approach. In approaching this synthesis, the target molecule was 
considered as having two main structural motifs: first, the fused tricyclic core, which Hiemstra et 
al. achieved through the [2+2] photocycloaddition chemistry; and the eight-membered ring, 
which they achieved through an intramolecular aldol reaction. Therefore, it was decided that the 
first goal of this project would be to synthesize a model system for aquatolide, focusing on the 
tricyclic core rather than the eight-membered ring. Thus the first synthetic goal for this research 
work was structure 32, shown below. 
 
 
 
 As indicated in scheme 2.1 above, Hiemstra et al. chose to use 30a as the starting 
material for the [2+2] photocycloaddition step. However, the other possible precursor would be 
the five-membered lactone 33, shown below; thus the photocycloaddition step planned for this 
synthesis differs from that used by Hiemstra et al. 
 
Scheme 2.2: Planned [2+2] photocycloaddition synthesis of model system 32 
 
2. Retrosynthesis 
 
Scheme 2.3: Retrosynthesis of aquatolide model system 32 
 
Retrosynthetically, model system 32 can be synthesized via a [2+2] photocycloaddition from 33, 
which is achievable through a number of steps culminating in a ring closing metathesis. 
Ultimately, the precursors for these structures can be achieved through aldol addition chemistry. 
 
3. Completed Work 
 
  
Scheme 2.4: Attempts towards a synthesis of a dimethyl ester 
 
First, isobutyric acid was added to auxiliary 41 to yield thione 42. An aldol addition of 
acrolein 40 to thione 42 was then attempted in order to try to make thione 43; however, the 
addition was not successful. A slightly different approach was attempted by the aldol addition of 
acrolein 40 to thione 39, yielding the Evans syn adduct, thione 44. Next, formation of ethyl ester 
45 was attempted with imidazole and catalytic DMAP in absolute ethanol, but was not able to be 
isolated in sufficient yield. 
 
 
Scheme 2.5: Towards the synthesis of aldehyde 36 
 
The previous step was repeated, with the addition of acrolein to thione 39 to yield thione 
44. Instead of attempting to form the ethyl ester, however, 44 was reacted with imidazole and 
isobutanol to give isobutyl ester 38. This product then underwent a Seebach alkylation to give 
ester 46. This was then protected with TBSCl to give TBS-protected ester 37 which underwent 
reduction with DIBAL to give aldehyde 36, which has not been successfully isolated.  
 
  
Chapter 3 
Experimental Methods and Supporting Data for Chapter 1 
 
 
10 
 
(S)-4-isopropylthiazolidine-2-thione To a 1 L flask was added KOH (50.0 g, 891 mmol) and 
300 mL of water. The solution was cooled to rt with an ice bath. L-valinol (15.3 g, 148 mmol) 
and CS2 (44 mL, 741 mmol) were added to the reaction. The reaction was heated, with stirring, 
under reflux overnight. The reaction was then allowed to cool to rt and then extracted 3x with 
CH2Cl2 (125 mL). The combined organic layers were dried over Na2SO4 and condensed by the 
removal of the solvent with a rotary evaporator. No purification was undertaken to yield the final 
product 10 (18.31 g, 85%). 
 
 
7 
 
(S)-1-(4-isopropyl-2-thioxothiazolidin-3-yl)propan-1-one In a 1 L flask, thiazolidinethione 10 
(18.3 g, 113 mmol) was dissolved in 200 mL dry CH2Cl2 and cooled to 0 °C under argon with 
stirring. Pyridine (11.4 mL, 141 mmol) was added via syringe. Propionyl chloride (11.9 mL, 136 
mmol) was added dropwise via syringe, yielding a yellow solution. The reaction was allowed to 
stir at 0 °C for an additional 30 min, then allowed to return to rt and stirred overnight. The 
reaction was then washed with 100 mL DI water, and this aqueous layer was extracted with 50 
mL CH2Cl2. The combined organic layers were washed with 1 N H2SO4, dried over MgSO4, and 
condensed on a rotary evaporator to give a yellow oil. This crude product was purified by flash 
chromatography (10% EtOAc/ hexanes) to yield the final product, thione 7 (17.95 g, 73%). 
1
H 
NMR (CDCl3, 400 MHz, ppm) δ 5.16 (t, J = 6.8, 1H), 3.50 (m, 1H), 3.35 (m, 1H), 3.34 (m, 1H), 
3.01 (m, 1H), 2.36 (m, 1H), 1.16 (t, J = 7.2, 3H), 1.05 (d, J = 6.8, 3H), 0.96 (d, J = 7.0, 3H). 
 
 
8 
1,1-dimethoxy-2-methylpropane A 50 mL volume of impure isobutyraldehyde was dried over 
MgSO4 and NaHCO3 and purified by distillation to give the dried, purified aldehyde. This 
purified isobutyraldehyde (24.89 g, 345.2 mmol) was added to a 250 mL flask, along with 70mL 
of methanol, and cooled to 0°C. The flask was then allowed to return to rt, and TsOH∙H2O (3.28 
g, 17.3 mmol) was added. The reaction stirred overnight at rt. The reaction was quenched with a 
solution of 10 mL saturated NaHCO3 in 140 mL water. The organic layer was collected, and the 
aqueous layer extracted with pentane (2 x 100 mL, 1 x 50 mL). The combined organic layers 
were dried over MgSO4 and condensed. The crude product was purified by distillation to give 
acetal 8 (19.67 g, 48%). 
1
H NMR (CDCl3, 400 MHz, ppm) δ 3.95 (d, J = 6.9, 1H), 3.34 (s, 6H), 
1.88 (m, 1H), 0.91 (d, J = 6.7, 6H). 
 
 
12 
 
(2R,3R)-1-((S)-4-isopropyl-2-thioxothiazolidin-3-yl)-3-methoxy-2,4-dimethylpentan-1-one 
Acylated thione 7 (15.9 g, 73.2 mmol) was dissolved in 366 mL CH2Cl2, under argon. The flask 
was cooled to 0 °C, and TiCl4 (8.85 mL, 80.52 mmol) was added via syringe and allowed to stir 
for 10 min, followed by i-Pr2NEt (14.02 mL, 80.52 mmol) dropwise via syringe. The dark red 
reaction stirred for 1 h at 0 °C. After 1 h, the reaction was cooled to –78 °C, and SnCl4 (8.57 mL, 
73.2 mmol) and acetal 8 (8.65 g, 73.2 mmol) were added via syringe. The reaction stirred for –78 
°C for another 30 min, and then was transferred to –20 °C overnight. The reaction was quenched 
with saturated ammonium chloride solution, and the aqueous layer extracted 2x with CH2Cl2. 
The combined organic layers dried over MgSO4 and evaporated. 
1
H NMR (CDCl3, 400 MHz, 
ppm) δ 5.27 (t, J = 6.8, 1H), 5.09 (m, 1H), 3.44 (m, 2H), 3.38 (s, 3H), 2.97 (d, J = 11.4, 1H), 2.33 
(m, 1H), 1.87 (m, 1H), 1.05 (m, 9H), 1.00 (d, J = 7.0, 3H), 0.89 (d, J = 6.8, 3H) 
 
 
6 
 
(2R,3R)-3-methoxy-2,4-dimethylpentanal In a flame dried 500 mL RBF cooled to –78 °C, 
thione 12 (7.42 g, 24.4 mmol) was dissolved in 244 mL dry CH2Cl2, with stirring, under argon. i-
Bu2AlH, 1 M in hexanes (48.8 mL, 48.8 mmol), was added slowly via syringe until the yellow 
color disappeared. The reaction was allowed to stir for 5 min. The reaction was quenched by 
addition to saturated Rochelle salt solution at 0 °C and was stirred at room temperature for 1 h. 
The aqueous layer was extracted with CH2Cl2 and the combined organic layers dried over 
MgSO4 and evaporated. The crude product was purified by flash chromatography (10% 
EtOAc/hexanes) to yield a colorless oil, aldehyde 6 (2.56 g, 82%). 
1
H NMR (CDCl3, 400 MHz, 
ppm) δ 9.77 (d, J = 2.3, 1H), 3.42 (s, 3H), 3.10 (t, J = 5.65, 3H), 2.61 (m, 1H), 1.87 (m, 1H), 1.09 
(d, J = 7.05, 3H), 0.94 (dd, J = 8.5, 6.9, 6H). 
 
 
16 
 
(1S,2R)-1-(((E)-3,5-di-tert-butyl-2-hydroxybenzylidene)amino)-2,3-dihydro-1H-inden-2-ol 
In a 100 mL flame dried RBF equipped with a stir bar, (1S, 2R)-(-)-cis-1-amino-2-indanol (448 
mg, 3.00 mmol) and 3,5-di-tert-butylsalicylaldhehyde (703 mg, 3.00 mmol) were dissolved in 
18.8 mL absolute ethanol and stirred at rt for 2 h. The yellow solution was then condensed, re-
dissolved in 18.8 mL of CH2Cl2, and condensed again. The flask was then placed under vacuum 
to give the solid product, ligand 16. 
1
H NMR (CDCl3, 400 MHz, ppm) δ 8.62 (s, 1H), 7.46 (d, J 
= 2.4, 1H), 7.32 (m, 2H), 7.21 (m, 3H), 4.85 (d, J = 5.3, 1H), 4.68 (q, J = 5.2, 1H), 3.25 (dd, J = 
16.0, 5.8, 1H), 2.14 (dd, J = 16.0, 4.8, 1H), 2.49 (br, 1H), 1.43 (s, 9H), 1.33 (s, 9H). 
 
 
18 
 
S-(tert-butyl) (R)-2-methylpropane-2-sulfinothioate In a 3-neck 500 mL RBF, ligand 16 (472 
mg, 1.29 mmol) and VO(acac)2 (337 mg, 1.27 mmol) were dissolved in 64 mL of acetone. The 
resulting dark green mixture was stirred at rt open to air for 30 min. After 30 min, t-butylsulfide 
(50 mL, 254.8 mmol) was added, and the solution was cooled to ~4 °C. Once cooled, 30% H2O2 
(32 mL, 396.8 mmol) was added over the course of 20 h, with stirring. At the end of the addition, 
the dark red solution was quenched at 0 °C by adding 75 mL saturated aqueous Na2S2O3 over the 
course of 1 h. The resulting light teal mixture was tested with starch/iodine paper to confirm that 
no peroxide remained. The layers were separated and the aqueous layer was extracted 3x with 
hexanes. The combined organic layers were washed with brine, dried over Na2SO4, and 
condensed, to yield thiosulfinate 18, an oil that was clean by NMR. 
1
H NMR (CDCl3, 400 MHz, 
ppm) δ 1.55 (s, 9H), 1.37 (s, 9H). 
 
 
19 
 
(R)-2-methylpropane-2-sulfinamide About 1.0 L of liquid NH3 was condensed into a flask at –
78°C and flushed with argon. Fe(NO3)3·9H2O (514.7 mg, 1.27 mmol) was added. Pieces of solid 
metallic lithium (8.842 g, 1.274 mol) were added in ~1 g portions, slowly, with constant 
adjustment of the –78°C bath to control refluxing. After all the lithium was added, the reaction 
was allowed to reflux for 15 min then cooled to –78°C. Thiosulfinate 18 (99.05 g, 509.6 mmol) 
was dissolved in 163 mL dry THF and added to the reaction via addition funnel over 45 min, 
with vigorous stirring. The reaction was stirred at –78°C for another 1 h. The reaction was then 
allowed to return to rt overnight with slow stirring, under argon. The reaction was then cooled to 
0°C, and ice (275.2 g, 15.29 mol) was added and stirred until mixture was homogenous. 
Chloroacetic acid (52.97 g, 560.6 mmol) was added slowly and the reaction stirred at rt over 48 
h. After 48 h, the dark red reaction was extracted 3x with 400 mL of CH2Cl2. The combined 
organic layers were dried over MgSO4 and condensed. The resulting red solid was dissolved in 
75 mL hexanes and condensed. This step was repeated once more before the resulting product 
was dried under vacuum to give a combination of white and red solids. The solid was then 
triturated with 125 mL hexanes. The precipitate was recrystallized in 75 mL of boiling hexanes, 
cooled to –20°C, and the solid collected by filtration. This recrystallization step was repeated 
once again to give a white solid product, sulfinamide 19 (34.25 g, 55.4%). 
1
H NMR (CDCl3, 400 
MHz, ppm) δ 4.06 (s, 2H), 1.14 (s, 9H). 
 
 
20 
 
(Z)-N-(2-chloroethylidene)-2-methylpropane-2-sulfinamide In a 3-neck 1 L RBF, 220.7 g 
CuSO4∙5H2O was flame dried to yield grey solid. The flask was equipped with a mechanical 
stirrer and placed under argon. To the flask was added 282.5 mL dry CH2Cl2, followed by 
sulfinamide 19 (17.13 g, 141.3 mmol) and chloroacetaldehyde (29.6 mL, 169.5 mmol) via 
syringe. The resulting sea green solution was allowed to stir overnight. The reaction was then 
filtered over celite and the resulting dark orange filtrate was dried over MgSO4 and condensed to 
give a crude product. This crude product was filtered through silica gel (25% EtOAc/hexanes) to 
give a final product imine 20 (17.44 g, 82%). 
1
H NMR (CDCl3, 400 MHz, ppm) δ 8.04 (t, J = 
4.6, 1H), 4.32 (d, J = 4.4, 2H), 1.22 (s, 9H). 
 
 
22 
 
(S)-4-mesitylthiazolidine-2-thione Into a flame-dried 3-neck 1 L RBF with stirring under argon, 
the mesityl Grignard was prepared in 120 mL diethyl ether from mesityl bromide (36.86 mL, 
240.85 mmol) and metallic Mg (5.85 g, 240.85 mmol). The flask was cooled to –78°C, and 
imine 20 (8.72 g, 48.17 mmol) in 241 mL toluene was added via addition funnel over 30 min. 
The reaction was allowed to stir for another 3 h. After 3 h, the reaction was quenched with 120.5 
mL of 4 M aqueous HCl solution and stirred overnight at rt. The quenched reaction was 
extracted 3x with water (100 mL). The combined layers were titrated to pH ~9 by the dropwise 
addition of 50% aqueous NaOH solution, with stirring, causing precipitation of a solid. The 
mixture was extracted 3x with diethyl ether (100 mL). The combined organic layers were dried 
over MgSO4 and condensed. This intermediate product was dissolved in minimal CH2Cl2 and 
transferred to a 500 mL RBF, and condensed on a rotary evaporator to remove the solvent. To 
this flask was added 241 mL of 1 M aqueous KOH solution and then CS2 (14.5 mL, 240.85 
mmol) via syringe. The flask was placed in an oil bath and allowed to stir, with heating, at reflux 
overnight. The reaction was then extracted 3x with CH2Cl2 (100 mL). The combined organic 
layers were dried over MgSO4 and condensed to give the crude product 22 which was taken 
forward (5.94 g, 52%). 
1
H NMR (CDCl3, 400 MHz, ppm) δ 7.30 (br, 1H), 6.88 (s, 2H), 5.84 (t, J 
= 10.4, 1H), 3.66 (dd, J = 10.29, 1.2, 2H), 2.40 (s, 6H), 2.27 (s, 3H). 
 
 
5 
 
(S)-1-(4-mesityl-2-thioxothiazolidin-3-yl)ethan-1-one In a flame-dried 500 mL flask, thione 22 
was dissolved in 100 mL CH2Cl2, under argon, with stirring. The flask was cooled to 0°C, and 
excess triethylamine (16.8 mL, 120.5 mmol) was added via syringe. The flask was then allowed 
to return to rt and acyl chloride (2.14 mL, 30.02 mmol) was added via syringe and allowed to stir 
at rt overnight. The reaction was quenched with 100 mL of saturated aqueous NH4Cl solution 
and extracted 2x with CH2Cl2 (50 mL). The combined organic layers were washed with 100 mL 
DI water, and then dried over MgSO4 and condensed. The crude product was purified by flash 
chromatography (7.5% EtOAc/hexanes) to give the final product thione 5 (5.35 g, 77%). 
1
H 
NMR (CDCl3, 400 MHz, ppm) δ 6.85 (s, 2H), 6.35 (t, J = 10.1, 1H), 3.55 (dd, J = 11.3, 10.4, 
1H), 3.33 (dd, J = 11.3, 9.8, 1H), 2.70 (s, 3H), 2.40 (s, 6H), 2.24 (s, 3H). 
 
 
 
23 
 
(3R,4S,5R)-3-hydroxy-1-((S)-4-mesityl-2-thioxothiazolidin-3-yl)-5-methoxy-4,6-
dimethylheptan-1-one In a flame-dried 250 mL RBF, thione 5 was dissolved in 87 mL dry 
CH2Cl2, with stirring, under argon. The flask was cooled to –78°C, and TiCl4 (2.12 mL, 19.17 
mmol) was added via syringe. After stirring 5 min, i-Pr2Net (4.10 mL, 23.53 mmol) was added 
via syringe, and the reaction stirred for 30 min. Aldehyde 6 was dissolved in minimal CH2Cl2 
and added to the reaction, which was allowed to stir for 1 h. The reaction was quenched by the 
addition of 90 mL of half-sat ammonium chloride, with stirring, and allowed to return to rt. The 
mixture was extracted 3x with CH2Cl2 (100 mL). The combined organic layer was dried over 
MgSO4 and condensed. The crude product was purified by flash chromatography (25% 
EtOAc/hexanes) to give a yellow solid product, thione 23 (3.93 g, 55.4%). 
1
H NMR (CDCl3, 400 
MHz, ppm) δ 6.83 (s, 2H), 6.39 (t, J = 9.95, 1H), 4.35 (m, 1H), 3.59 (m, 2H), 3.43 (s, 3H) 3.33 
(dd, J = 11.28, 9.52, 1H), 3.24 (d, J = 2.54, 1H), 3.12 (dd, J = 17.21, 4.46, 1H), 2.82 (t, J = 5.86, 
1H), 2.40 (s, 6H), 2.23 (s, 3H), 1.84 (m, 1H), 1.40 (m, 1H), 0.88 (dd, J = 14.98, 6.89, 6H), 0.77 
(d, J = 6.81, 3H); 
13
C NMR (CDCl3, 100 MHz, ppm) δ 201.54, 174.28, 137.84, 132.77, 90.94, 
68.15, 67.44, 62.05, 45.03, 38.64, 32.52, 30.52, 20.86, 20.36, 20.34, 20.31, 19.93, 17.42, 11.28; 
IR (thin film) ν 3480, 2968, 2872, 1713, 1610, 1456, 1260, 1174, 909, 729. 
 
 
24 
 
(3R,4R,5R)-1-((S)-4-mesityl-2-thioxothiazolidin-3-yl)-5-methoxy-4,6-dimethyl-3-
((triethylsilyl)oxy)heptan-1-one In a flame dried 50 mL RBF, thione 23 (3.39 g, 9.65 mmol) 
was dissolved in 20 mL of dry CH2Cl2, and the flask cooled to 0°C, with stirring and under 
argon. To this was added 2,6-lutidine (2.26 mL, 19.3 mmol) followed by TES triflate (2.89 mL, 
12.55 mmol). The reaction progress was monitored by TLC (10% EtOAc/90% hexanes), with 
points taken at 45 min and 75 min. After 75 min a further 300 μL TES triflate was added and 
stirred for an additional 15 min before being quenched with 20 mL saturated sodium bicarbonate 
solution and allowed to return to rt. The quenched reaction was extracted 3x with CH2Cl2. The 
combined organic fractions were dried over MgSO4 and condensed. The crude product was 
purified by flash chromatography (7.5% EtOAc/hexanes) to yield the final product 24 (5.03 g, 
96%) with some contamination by 2,6-lutidine starting material by NMR. Unprotected thione 
starting material was recovered from the column by flushing with 30% EtOAc/hexanes. 
1
H NMR 
(CDCl3, 400 MHz, ppm) δ 6.84 (s, 2H), 6.38 (t, J = 10.09, 1H), 4.59 (m, 1H), 3.71 (dd, J = 17.84, 
4.80, 1H), 3.56 (t, J = 10.88, 1H), 3.38 (s, 3H), 3.28 (m, 2H), 2.85 (d, J = 8.90, 1H), 2.44 (s, 6H), 
2.25 (s, 3H), 1.73 (m, 1H), 0.98 (m, 16H), 0.63 (m, 14H); 
13
C NMR (CDCl3, 100 MHz, ppm) δ 
200.71, 172.89, 137.74, 132.46, 129.01, 128.21, 125.30, 86.95, 68.09, 67.90, 60.72, 46.03, 39.51, 
32.29, 26.92, 20.96, 20.71, 15.14, 9.89, 7.07, 6.81, 6.46, 5.54; IR (thin film) ν 3405, 2956, 2830, 
2731, 2244, 1714, 1611, 1456, 1260, 850, 741. 
 
 
4 
 
(3R,4R,5R)-5-methoxy-4,6-dimethyl-3-((triethylsilyl)oxy)heptanal In a flame dried 250 mL 
RBF cooled to –78 °C, thione 24 (4.87 g, 9.34 mmol) was dissolved in 93.4 mL dry CH2Cl2, 
with stirring, under argon. To this, 1 M i-Bu2AlH in hexanes (18.67 mL, 18.67 mmol) was added 
via syringe. The yellow color of the solution persisted, so another 3 mL (3 mmol) of i-Bu2AlH in 
hexanes was added. The reaction was allowed to stir for 3 min, and then was quenched by 
addition to saturated Rochelle salt solution. The quenched reaction mixture was stirred 
vigorously at room temperature for 45 min. The aqueous layer was extracted 3x with CH2Cl2 and 
the combined organic layers washed first with DI water and then with brine. The final organic 
layers were dried over MgSO4 and condensed. The crude product was purified by flash 
chromatography (5% EtOAc/hexanes) to give the final product aldehyde 4 (1.52 g, 53%). 
1
H 
NMR (CDCl3, 400 MHz, ppm) δ 9.78 (t, J = 2.5, 1H), 4.60 (td, J = 6.3, 2.5, 1H), 3.47 (s, 3H), 
2.95 (dd, J = 8.6, 2.9, 1H), 2.61 (m, 2H), 1.86 (m, 1H), 1.55 (m, obscured by HOH peak), 0.97 
(m, 15H), 0.84 (t, J = 7.0, 6H), 0.62 (q, J = 8.0, 6H); 
13
C NMR (CDCl3, 100 MHz, ppm) δ 
201.37, 87.38, 67.57, 61.01, 50.84, 42.27, 30.16, 21.04, 15.71, 10.68, 7.00, 6.49, 5.55; IR (thin 
film) ν 2958, 2877, 2718, 1730, 1461, 1385, 1299, 1093, 1009, 742. 
 
 
25 
 
(2S,3R,5R,6R,7R)-1-((S)-4-benzyl-2-thioxothiazolidin-3-yl)-2-ethyl-3-hydroxy-7-methoxy-
6,8-dimethyl-5-((triethylsilyl)oxy)nonan-1-one In a flame dried 250 mL RBF, thione auxiliary 
3 (1.404 g, 5.02 mmol) was dissolved in 50 mL dry CH2Cl2 and cooled to 0°C, under argon, with 
stirring. TiCl4 (0.579 mL, 5.27 mmol) was added via syringe, and the reaction stirred for 5 min. 
i-Pr2NEt (1.84 mL, 10.54 mmol) was added, and the reaction stirred for 30 min. After 30 min, 
the reaction was cooled to –78°C and NMP (0.603 mL, 6.28 mmol) was added and the reaction 
stirred another 10 min. Aldehyde 4 was dissolved in 5 mL CH2Cl2 and added to the reaction, and 
stirred for 1 h. The reaction was quenched with half-sat ammonium chloride, and extracted 3x 
CH2Cl2. The combined organic layers were dried over MgSO4 and condensed. The crude product 
was purified by flash chromatography (15% EtOAc/hexanes) to give the yellow final product 25 
(1.59 g, 54%). 
1
H NMR (CDCl3, 400 MHz, ppm) δ 7.30 (m, 5H), 5.33 (m, 1H), 4.90 (m, 1H), 
4.16 (m, 1H), 4.11 (m, 1H), 3.48 (d, J = 10.2, 1H), 3.48 (s, 1H), 3.34 (dd, J = 11.3, 7.0, 1H), 3.25 
(m, 2H), 3.07 (dd, J = 13.1, 10.7), 2.87 (m, 2H), 1.99 .. 1.60 (br m, 7H), 0.79 (m, 16H), 0.87 (m, 
6H), 0.63 (m, 6H); 
13
C NMR (CDCl3, 100 MHz, ppm) δ 201.89, 176.40, 136.78, 129.58, 129.04, 
127.33, 87.88, 71,93, 70.45, 69.53, 60.62, 50.62, 40.87, 39.94, 37.02, 32.01, 30.18, 21.37, 20.19, 
16.56, 12.02, 11.91, 7.16, 5.51; IR (thin film) ν 3437, 2959, 2875, 2359, 1696, 1456, 1340, 1264, 
1164, 742. 
 
 
26 
 
(2S,3R,5R,6R,7R)-1-((S)-4-benzyl-2-thioxothiazolidin-3-yl)-2-ethyl-7-methoxy-6,8-dimethyl-
3,5-bis((triethylsilyl)oxy)nonan-1-one Thione 25 (1.59 g, 2.73 mmol) was dissolved in 14 mL 
of dry CH2Cl2, and the flask cooled to 0°C, with stirring and under argon. To this was added 2,6-
lutidine (0.639 mL, 5.46 mmol) followed by TES triflate (0.907 mL, 4.01 mmol). The reaction 
stirred at room temperature for 30 min. The reaction progress was checked by TLC (10% 
EtOAc/90% hexanes) and an additional 0.64 mL (5.5 mmol) of 2,6-lutidine and 0.91 mL (4.1 
mmol) of TES triflate were added. The reaction stirred for an additional 15 min before being 
quenched with 20 mL saturated sodium bicarbonate solution and allowed to return to rt. The 
quenched reaction was extracted 3x with CH2Cl2. The combined organic fractions were dried 
over MgSO4 and condensed. The crude product was purified by flash chromatography (1.5% 
EtOAc/hexanes) to yield the final product 26 (1.52 g, 80%). 
1
H NMR (CDCl3, 400 MHz, ppm) δ 
7.31 (m, 5H), 5.24 (m, 1H), 4.75 (m, 1H), 4.10 (dd, J = 8.6, 4.5), 3.99 (q, J = 5.6, 1H), 3.46 (s, 
3H), 3.33 (m, 2H), 3.06 (dd, J = 13.1, 10.9, 1H), 2.97 (dd, J = 9.5, 1.8, 1H), 2.85 (d, J = 11.4, 
1H), 1.99 .. 1.76 (br m, 5H), 1.73 .. 1.62 (br m, 2H), 1.56 (m, 1H), 0.97 (m, 28H), 0.81 (dd, J = 
32.2, 6.8, 6H), 0.64 (m, 14H), 0.52 (q, J = 8.0, 1H); 
13
C NMR (CDCl3, 100 MHz, ppm) δ 201.13, 
176.07, 137.07, 129.65, 129.04, 127.27, 86.88, 71.30, 69.89, 69.58, 61.43, 51.58, 61.43, 51.58, 
42.32, 40.69, 36.79, 32.13, 30.11, 21.62, 21.48, 15.36, 12.09, 9.85, 7.34, 7.21, 6.17, 5.39; IR 
(thin film) ν 2956, 2911, 2875, 2830, 2733, 1695, 1457, 1341, 1264, 1165, 1088, 1009, 742. 
 
 
2 
 
(2S,3R,5R,6R,7R)-2-ethyl-7-methoxy-6,8-dimethyl-3,5-bis((triethylsilyl)oxy)nonanal Thione 
26 (1.52 g, 2.18 mmol) was dissolved in 22 mL dry CH2Cl2, in a flame dried 50 mL RBF under 
argon, and cooled to –78°C. i-Bu2AlH (4.80 mL, 4.80 mmol) was added via syringe. After all the 
yellow color had disappeared, the reaction was quenched by addition to sat. Rochelle salt, with 
vigorous stirring, and allowed to stir for 1 h. The quenched reaction was then extracted 3x with 
CH2Cl2, and the combined organic layers washed with DI water and with brine. The organic 
layer was dried over MgSO4 and condensed. This crude product was filtered through silica gel 
with 2.5% EtOAc/hexanes to give a clear oil for the pure product 2 (0.645 g, 61%). 
1
H NMR 
(CDCl3, 400 MHz, ppm) δ 9.71 (s, 1H), 4.12 (td, J = 7.1, 2.5, 1H), 3.99 (t, J = 7.3, 1H), 3.44 (s, 
3H), 2.96 (dd, J = 9.6, 1.9, 1H), 2.17 (d, J = 9.4, 1H), 1.81 (m, 4H), 1.56 .. 1.41 (br m, 2H), 0.94 
(m, 26H), 0.79 (dd, J = 23.7, 6.9, 6H), 0.59 (m, 13H); 
13
C NMR (CDCl3, 100 MHz, ppm) δ 
205.29, 86.76, 69.50, 69.12, 61.44, 57.81, 40.39, 40.17, 30.02, 21.29, 16.25, 15.04, 12.78, 9.31, 
7.21, 7.10, 6.98, 6.95, 6.59, 6.01, 5.27; IR (thin film) ν 2958, 2877, 2829, 2713, 2360, 1725, 
1450, 1090, 1007, 742. 
 
 
28 
 
Ethyl (4R,5R,7R,8R,9R,Z)-4-ethyl-9-methoxy-8,10-dimethyl-5,7-bis((triethylsilyl)oxy)undec-
2-enoate Phosphonate ester 27 (550 mg, 1.72 mmol) was dissolved in 9 mL THF in a 50 mL 
RBF under argon, with stirring. NaI (197.7 mg, 1.319 mmol) was added and the reaction cooled 
to 0°C. After 5 min, NaH as a 60% dispersion in mineral oil (75 mg, 1.88 mmol) was added and 
stirred for 15 min. After 15 min, the reaction was cooled to –78°C, and aldehyde 2 (645 mg, 
1.319 mmol) dissolved in 3 mL THF was added. The reaction, having turned yellow, was 
warmed to 0°C and stirred for 1.5 h. The cloudy yellow reaction was quenched with 15 mL sat 
ammonium chloride solution. The resulting orange mixture was worked up with diethyl ether, 
dried over MgSO4, and condensed. The crude product was purified by flash chromatography (2% 
EtOAc/hexanes) to give an off-clear oil for the final pure product 28 (546 mg, 74%). 
1
H NMR 
(CDCl3, 400 MHz, ppm) δ 6.11 (dd, J = 11.6, 10.4, 1H), 5.82 (d, J = 11.7, 1H), 4.13 (m, 3H), 
3.70 (m, 1H), 3.45 (s, 3H), 3.40 (m, 1H), 2.98 (dd, J = 9.4, 1.9, 1H), 1.83 (m, 2H), 1.76 .. 1.61 
(br m, 3H), 1.36 (m, 1H), 1.25 (t, J = 7.1, 3H), 0.95 (m, 23H), 0.85 (m, 7H), 0.74 (d, J = 6.9, 3H), 
0.59 (m, 13H); 
13
C NMR (CDCl3, 100 MHz, ppm) δ 166.20, 152.28, 120.64, 86.97, 72.47, 69.33, 
61.40, 59.81, 44.50, 41.31, 40.06, 30.13, 21.68, 21.46, 15.19, 14.41, 11.85, 9.44, 7.25, 7.20, 7.11, 
6.10, 5.42; IR (thin film) ν 2958, 2911, 2876, 2830, 2733, 2359, 2342, 1723, 1644, 1459, 1414. 
 
 
1 
 
Pironetin analogue 1 Ester 28 (546 mg, 0.978 mmol) was dissolved in a solvent system 
composed of 9 mL benzene plus 1 mL of MeOH in a 100 mL RBF. PPTS (25 mg, 0.0978 mmol) 
was added and allowed to stir 30 min. The reaction was then heated to 70°C and stirred for 2 h. 
The reaction was monitored by TLC (5% EtOAc/hexanes; 20% EtOAc/hexanes; 40% 
EtOAc/hexanes) at time points after 30 min at rt and then every 15 min starting after 1 hr at 
70°C. After 2 h at 70°C, the solvent was removed by rotary evaporation. The crude product was 
purified by flash column chromatography (30% EtOAc/hexanes → 40% EtOAc/hexanes → 75% 
EtOAc/hexanes) to obtain pironetin analogue 1 (132 mg, 47.5%). 
1
H NMR (CDCl3, 400 MHz, 
ppm) δ 6.99 (dd, J = 9.7, 6.0, 1H), 6.0 (d, J = 9.8, 1H), 4.72 (m, 1H), 4.22 (t, m, 1H), 3.47 (s, 
3H), 3.23 (br, 1H), 2.82 ( dd, J = 8.1, 3.1), 2.26 (m, 1H), 1.96 (m, 1H), 1.69 (m, 5H), 1.48 (m, 
1H), 0.99 (m, 9H), 0.86 (d, J = 6.8, 3H); 
13
C NMR (CDCl3, 100 MHz, ppm) δ 164.91, 150.87, 
120.92, 94.08, 66.97, 62.12, 39.27, 38.68, 37.12, 31.22, 20.89, 20.00, 19.27, 12.25, 11.13; IR 
(thin film) ν 3483, 2965, 2935, 2877, 2833, 1721, 1462, 1385, 1252, 1083. 
 
  
Chapter 4 
Experimental Methods and Supporting Data for Chapter 2 
 
 
 
44 
 
1-((R)-4-benzyl-2-thioxothiazolidin-3-yl)-3-hydroxy-2-methylpent-4-en-1-one Propanone 
thione 39 (10 g, 37.7 mmol) was dissolved in 377 mL dry CH2Cl2 and cooled to 0°C, under 
argon, with stirring. TiCl4 (4.56 mL, 41.4 mmol) was added via syringe and the reaction stirred 5 
min. i-Pr2NEt (13.8 mL, 79.2 mmol) was added via syringe and the reaction stirred 30 min. NMP 
(4.52 mL, 47.1 mmol) was added, and the reaction cooled to –78°C and stirred for 10 min. After 
10 min, acrolein 40 (2.52 mL, 37.7 mmol) was added and the reaction stirred 1 h. The reaction 
was quenched with half-saturated ammonium chloride and allowed to return to room 
temperature. The reaction was extracted 3x with CH2Cl2 and the organic layers dried over 
Na2SO4. The crude product was purified by flash column chromatography (10% EtOAc/hexanes 
→ 15% EtOAc/hexanes) to give a yellow oil as the final product 44 (5.4 g, 45%). 1H NMR 
(CDCl3, 400 MHz, ppm) δ 7.34 (m, 2H), 7.27 (m, 3H), 5.84 (m, 1H), 5.33 (dd, J = 17.3, 1.1, 1H), 
5.33 .. 5.27 (m, 1H), 5.21 (dd, J = 10.6, 0.8, 1H), 4.57 (m, 1H), 4.47 (m, 1H), 3.39 (dd, J = 11.5, 
7.2, 1H), 3.23 (dd, J = 13.1, 3.7, 1H), 3.05 (m, 1H), 2.90 (d, J = 11.5, 1H), 2.18 (br, 1H), 1.25 (d, 
J = 6.8, 3H). 
 
 
38 
 
Isobutyl 3-hydroxy-2-methylpent-4-enoate Thione 44 (5.4 g, 16.8 mmol) was dissolved in 40 
mL dry CH2Cl2, with stirring. Imidazole (1.72 g, 25.2 mmol) and isobutanol (15.5 mL, 168.0 
mmol) were added, and the reaction stirred overnight, under argon, at rt. The reaction was 
quenched with DI water and extracted 2x with CH2Cl2. The combined organic layers were dried 
over Na2SO4 and the solvent evaporated, causing off white solid to appear. This crude product 
was diluted in hexanes and minimal EtOAc, and washed 2x with 1 M NaOH solution. The 
organic layer was again condensed. This crude product was purified by flash column 
chromatography (10% EtOAc/hexanes) to give the final product 38 (1.95 g, 62%). 
1
H NMR 
(CDCl3, 400 MHz, ppm) δ 5.84 (m, 1H), 5.32 (dt, J = 17.2, 1.53, 1H), 5.21 (dt, J = 10.6, 1.5, 
1H), 4.42 (m, 1H), 3.90 (m, 2H), 2.66 (m, 1H), 2.25 (br s, 1H), 1.94 (m, 1H), 1.18 (d, J = 7.2, 
3H), 0.94 (d, J = 6.7, 6H). 
 
46 
 
Isobutyl 3-hydroxy-2,2-dimethylpent-4-enoate A flame-dried 3 neck 250 mL RBF was 
equipped with a stir bar, addition funnel, argon line, and low-temperature thermometer. Freshly-
distilled diisopropylamine (4.40 mL, 31.41 mmol) and 55 mL freshly-distilled THF were added 
via syringe, and the flask cooled to –78°C. n-Butyllithium (16.4 mL, 26.18 mmol) was added 
dropwise via syringe, and the reaction stirred 40 min at –78°C. Ester 38 (1.95 g, 10.47 mmol) 
was dissolved in 15 mL dry freshly-distilled THF and added dropwise via addition funnel over 
10 min. The reaction was then warmed to –20°C and stirred 30 min. After 30 min, the reaction 
was cooled again to –78°C, and iodomethane (6.42 mL, 104.7 mmol) was added via syringe, and 
the flask was placed in a –20°C freezer for 2.5 days. The reaction was quenched with 1:1 (v:v) 
acetic acid:diethyl ether. The quenched reaction was allowed to return to rt, with stirring, and 
then was poured into 200 mL 1:1 diethyl ether:water mixture. This was extracted 3x with diethyl 
ether (50 mL), and the combined organic layers dried over Na2SO4. 
1
H NMR of the crude 
product looked clean for the expected product so no purification was undertaken and the crude 
product was taken forward as ester 46 (1.81 g, 86%). 
1
H NMR (CDCl3, 400 MHz, ppm) δ 5.86 
(m, 1H), 5.31 (dt, J = 17.1, 1.5, 1H), 5.22 (dt, J = 10.4, 1.4, 1H), 4.17 (dt, J = 6.5, 1.1, 1H), 3.88 
(d, J = 6.6, 2H), 2.42 (br s, 1H), 1.95 (m, 1H), 1.20 (s, 3H), 1.18 (s, 3H), 0.94 (d, J = 6.7, 6H). 
 
 
37 
 
Isobutyl 3-((tert-butyldimethylsilyl)oxy)-2,2-dimethylpent-4-enoate Ester 46 (1.81 g, 9.04 
mmol) was dissolved in 100 mL. TBSCl (1.51 g, 10.0 mmol) and imidazole (1.28 g, 18.8 mmol) 
were added and the reaction stirred for 3 d. An additional 1 g and an additional 0.85 g of 
imidazole were added and the reaction stirred overnight. The reaction was quenched with 100 
mL of water, and then extracted 2x with CH2Cl2. The combined organic layers were dried over 
Na2SO4 and condensed. This crude product was purified by flash column chromatography (10% 
EtOAc/hexanes) to give the final product ester 37 (1.35 g, 48%). 
1
H NMR (CDCl3, 400 MHz, 
ppm) δ 5.75 (m, 1H), 5.16 (m, 2H), 4.29 (d, J = 7.5, 1H), 3.87 .. 3.76 (m, 2H), 1.93 (m, 1H), 1.15 
(s, 3H), 1.06 (s, 3H), 0.94 (d, J = 6.7, 6H), 0.86 (s, 9H), 0.02 (s, 3H), 0.01 (s, 1H). 
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